ACORN

Memphis, Tennessee 38138

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer

Studies at this site

• Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) — Stopped early
• Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC — Completed